Target ALS Foundation, Inc.

The goal of Target ALS is to increase the number, robustness and intensity of ALS drug development programs in the pharma/biotech industry by supporting the best preclinical research and fostering interactions between academia and industry. Given our success in building this bridge over the past two years, our central strategy now is to validate novel therapeutic targets – molecular steps in the disease pathway which, when blocked by a drug, can slow or prevent disease progression – to be built upon by the industry.